Pluto Bio provides a multi-omics platform for translational discovery in the field of bioinformatics and genomics research.

Pluto Bio

Drug discovery just got a modern upgrade. Pluto is the collaborative, AI-powered solution empowering scientific teams to do target and biomarker discovery, faster than ever before. Build your biomarker and target lists, track status, priority, and evidence in powerful reports. Visualize and analyze multi-omics data sets with no coding required, and create compelling figures for high-impact presentations. Integrate the wealth of knowledge from published literature and data sets to gain a competitive advantage and derisk projects earlier for better results.

Curious how to leverage complex data sets in a way that's meaningful to scientists? Catch Pluto Bio and CEO Rani Powers, PhD at the Bioprocessing Summit in Boston this week.

#digitaltransformation #dataanalysis #discovery

Thank you to everyone that joined us for our free webinar today on telling compelling scientific stories through data! 👩🏻💻🧬

In this session, we used Pluto's user-friendly analysis library, infinite canvas editor, dynamic methods sections, supplemental tables & automated GEO submissions to explore how you can go from raw data to high-quality figures for publication.

In case you missed it, you can still get the recording on-demand: https://lnkd.in/gTxKkzGg

Ready to start your own analysis journey? Chat with us! https://pluto.bio/get-info

#datavisualization #research #omics

Translational science teams juggle impressive amounts of data, exploratory research, and knowledge from proprietary and published evidence sources. Join us for our upcoming webinar diving into strategies for effectively managing these critical sources of information, and integrating them to drive scientific insight and outcomes.

🚀 Register now: https://lnkd.in/grDN48Ca

P.S. Academic labs, we have an upcoming session for you too! Join our free, publication-focused webinar August 14th: https://lnkd.in/gTxKkzGg

#drugdiscovery #targetdiscovery #biomarkerdiscovery #translationalscience

At its annual Sponsors and Partners Meeting, the Wyss Institute at Harvard University Brain Targeting Program announced that it will use Pluto Bio's target discovery software platform to analyze & visualize -omics data, curate evidence from published literature & other sources, and integrate these findings with expert insight from their scientists to efficiently identify, score, and prioritize lead panels of brain shuttles.

Delivery of drugs across the blood-brain barrier and into the brain continues to present one of the greatest challenges in medicine, and causes drugs for Alzheimer’s disease, brain cancers, and more to frequently fail in the clinic. The Brain Targeting Program is advancing the field of brain delivery by identifying targets that can be fused with drugs, enabling safe and effective brain-targeted therapeutics.

We are proud that Pluto's modern platform for drug discovery will be empowering this world-class team advancing next-generation approaches for delivering treatments to the brain!

Read more: https://lnkd.in/g7aYPVcj

#targetdiscovery #therapeutics #bloodbrainbarrier

🧬 Considering doing some RNA-seq experiments for #targetdiscovery or #biomarkerdiscovery? Our 101 tutorials run through the basics of the data processing and analysis steps you'll need to address your scientific questions of interest. 

Learn more at https://lnkd.in/gvYPnG2X

#bioinformatics #pharma #biotech

💬 Currently, researchers studying cancer, diabetes, and other life-threatening diseases are using Pluto Bio in their work. “That for me is one of the most rewarding parts of the business: getting to see real discoveries,” says Powers.

This month in a ColoradoBiz tech start-up highlight, founder Rani Powers, PhD  discusses how Pluto is helping scientists analyze complex data needed to understand disease and develop better drugs.

Check out the feature: https://lnkd.in/gapsaNKs

The 2024 Q2 Product Awards, hosted by Products That Count in partnership with Capgemini and Mighty Capital, are all about how Product is leading business into the future. We are thrilled to announce that Pluto received an award for our AI-boosted multi-omics analysis platform, which enables biopharma companies to gain insight from complex data sets in order to develop better drugs.

Read more: https://lnkd.in/gzRcT8Zr

#productmanagement #2024productawards #pharma #biotech #scrnaseq

It was an amazing few days representing Pluto Bio at the #InnovatorSummit2024, and I’m grateful to have connected with the alumni, mentors, and partners that are part of this amazing ecosystem.

Our selection for this cohort is a testament to the impact our platform has on accelerating drug discovery by making multi-omics data analysis accessible to every scientist. 

We’re thrilled to be part of the BioTools Innovator cohort and look forward to the journey ahead! 

#biotools #lifesciencetools #biotech #datavisualization #bioinformatics #computationalbiology #multiomics #pharma

The Pluto team is looking forward to participating in the BioTools Innovator Summit next month and connecting with the rest of this year's dynamic cohort! 

See you soon Anvil Diagnostics, Autolomous, Axolotl Biosciences, CellRev, Cerillo, CytoRecovery, Inc., EmGenisys, EpiPaws, FemtoFluidics, Life Magnetics, Narwhal Bio Inc., Nyctea Technologies, Polybiomics Inc., QurCan Therapeutics Inc., React4life, Redbud Labs, Ryght, Sarcura , and Syenex 

Read the full press release: https://lnkd.in/dFDVpgXd

We're thrilled to announce that Pluto has been selected as one of 20 companies in the 2024 cohort of the BioTools Innovator Accelerator, the first accelerator dedicated to supporting life science tools. 

From Kathryn Zavala, Managing Director: "BioTools Innovator’s mission is to nurture the life science entrepreneurs whose technologies enable more efficient drug discovery and development processes.”

At Pluto, we're driven by the mission to accelerate drug discovery by making multi-omics data analysis accessible to every scientist. Our selection for this ground-breaking cohort is a testament to the impact our platform is already making for scientists in biopharma, and represents an exciting opportunity for Pluto to expand with the expertise of distinguished thought leaders in the biotools industry.

Congratulations to all of the companies selected!

Read the press release: https://lnkd.in/giF4HCi4

Learn more about Pluto: https://pluto.bio

news impact assignment basic	general
public peers	general	Aug 31, 2024 11:15 PM	f3367285
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Aug 31, 2024 11:15 PM	98dbf8cc
translate crunchbase fundingrounds	general
peers	general	Aug 31, 2024 11:15 PM	add52601
news basic	general	Aug 31, 2024 11:15 PM	ef4a4e49
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

BIO:PLUTO

Pluto Bio